REQUEST A DEMO
Total
USD $0.00
Search more companies

Dongkook Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dongkook Pharmaceutical Co.,Ltd. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dongkook Pharmaceutical Co.,Ltd. is engaged in manufacturing of pharmaceutical products. The company offer OTC (over the counter) drugs including Alprostadil injection, Teicoplanin injection, Propofol injection, Tritorelin depot injection, Iopamidol injection, Octreotide Lar injection, Gadopentate Dimeglumin injection, Leuprorelin Acetate injection, Sodium Hyaluronate injection and Streptokinase injection. Dongkook Pharmaceutical Co.,Ltd. alsos provides medicines for gingival disease, herbal-compound wound care ointment, medicine for menopause, anticancer products, as well as medical devices such as Bellast injection, Surgiquest, parasurgical and other medical components. The company is based in Seoul, South Korea. Dongkook Pharmaceutical Co.,Ltd. was incorporated in 1968.

Headquarters
997-8 Daechi 3-Dong, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Dongkook Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.dkpharm.co.kr

Basic Information
Total Employees:
Purchase the Dongkook Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Dongkook Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Dongkook Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Dongkook Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
October 15, 1968
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
20.16%
Purchase this report to view the information.
19.91%
Purchase this report to view the information.
4.89%
Purchase this report to view the information.
0.93%
Purchase this report to view the information.
0.6%
Subsidiaries
동국생명과학
57.27%
멀티에셋전문투자형사모부동산제이호투자유한회사
28.57%
디티알비전사모투자합자회사
26.36%
Company Performance
Financial values in the chart are available after Dongkook Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-91.7%
Total operating revenue
-91.72%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-87.4%
Total equity
-89.53%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
28.55%
Quick Ratio
-0.61%
Cash Ratio
-0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?